Bacterial and fungal pathogens isolated from patients with bloodstream infection: Frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial surveillance Program (2012–2017)
21 February 2020
The SENTRY Antimicrobial Surveillance Program has monitored bloodstream infections (BSI) from patients in medical centers worldwide since 1997. In this report, we examine the frequency of occurrence and antimicrobial susceptibility profiles of 6741 bacterial and 222 fungal pathogens causing BSI in 16 medical centers from 2012 to 2017. These results were stratified according to patient age, intensive care unit (ICU) location, and hospital onset (HO) versus community onset (CO) of infection.
Further reading: Diagnostic Microbiology and Infectious Disease
Author(s): Michael A. Pfaller et al
Effective Surveillance
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
